Navigation Links
Resonant Medical Expands Sales Organization with Appointment of Vice President of Global Sales and Marketing

MONTREAL, April 30 /PRNewswire/ -- Resonant Medical, an innovator in 3D ultrasound image-guided adaptive radiotherapy products, today announced the appointment of Stephen Whisenhunt to the position of Vice President of Global Sales and Marketing. Whisenhunt will lead the Company's growing global sales team and manage partnerships with distributors.

Whisenhunt brings more than 18 years of radiation oncology industry experience to the Company. Prior to joining Resonant Medical, Whisenhunt served as Vice President of International Sales at Xoft, Inc., as well as Vice President of Computed Tomography at Phillips Medical. Prior to that, Whisenhunt held the position of Vice President and General Manager of Oncology Business at Picker Medical Systems and spent four years as the Director of Oncology Marketing for GE Medical Systems. Stephen is a member of The New York Academy of Sciences and holds degrees from La Salle University and Frederick Taylor University.

"Stephen's experience in the radiation oncology market and proven track record of success will be a great asset to Resonant Medical as we continue to grow our United States customer base," said Tony Falco, president and founder of Resonant Medical. "Stephen will play a pivotal role in expanding our market presence, meeting the market's demand for the Clarity System and managing our relationships with our distributors. We are pleased to welcome him to the executive team and look forward to seeing the benefits of his leadership and proven sales execution abilities."

"Resonant's technology provides a solution for a clearly unmet need in breast cancer treatment--addressing the issue of tumor movement for breast and prostate cancer patients in a way that has never been done before," said Whisenhunt. "It is exciting to be part of a growing organization producing state-of-the-art technology to help so many patients in need. I look forward to using my knowledge and experience in this industry to help foster the growth of the company, bringing this technology to patients undergoing radiation therapy."

Recently, Resonant Medical also entered into a partnership with Radiation Oncology Systems to distribute the Clarity System in the southwest region of the United States. Radiation Oncology Systems is a comprehensive provider of radiation therapy and diagnostic imaging equipment and services.

About Resonant Medical

Resonant Medical (Montreal, Canada) develops, manufactures and commercializes 3D ultrasound image-guided adaptive radiotherapy products. Originally developed at McGill University Health Center, Resonant's technologies are available in more than 50 cancer centers in the U.S., Canada and Europe, helping cancer centers make significant improvements in radiation therapy planning, verification and delivery -- advancing patient care. Resonant can be found on the Web at

    Contacts: Wendy Ryan/Jasmine Fielding
    Schwartz Communications
    (781) 684-0770

SOURCE Resonant Medical
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
5. BioMS Medical announces its intention to renew a normal course issuer bid
6. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
7. ATS Medical Expands Open Pivot Heart Valve Offerings
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Globus Medical Announces Record 2nd Quarter 2007 Results
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. China Medical Technologies Reports First Quarter Financial Results
Post Your Comments:
(Date:10/12/2015)... This report covers the global cell expansion ... applications, end-user markets and geographic segmentation. Forecasts are provided ... cell expansion market generated revenue of roughly $8.5 billion ... $9.7 billion in 2015 and $22.0 billion by 2020, ... from 2015 to 2020. This report provides: ...
(Date:10/12/2015)... Oct. 12, 2015  Patara Pharma, a clinical-stage ... inflammatory diseases and conditions, today announced the closing ... financing. Concurrent with the close of its sale ... Loan and Security Agreement with Silicon Valley Bank ... million. Patara will use the funds from the ...
(Date:10/12/2015)... ... October 12, 2015 , ... NeuMedics Inc., is a specialty biopharmaceutical company focused ... safely and chronically be administered as an eye drop, announced today it has been ... Clinic and taking place October 25th to October 28th at The Cleveland Clinic, Cleveland, ...
(Date:10/9/2015)... ANNAPOLIS, Md. , Oct. 9, 2015 ... entered into the Congressional Record her statement recognizing the ... celebrated October 11-17. IPAW is sponsored by the ... companies, and is designed to:   , Raise ... contributions of plasma donors in saving and improving lives ...
Breaking Biology Technology:
(Date:9/30/2015)... , Sept. 30, 2015  With nearly 300,000 Americans ... of new SCIs estimated to reach 12,500 annually, the ... California Resource Services for Independent Living (SCRS-IL) is ... California opening doors to independence ... programs and services, notably assistive technology services and education. ...
(Date:9/29/2015)... 29, 2015 News facts: ... also saving energy , Minimized design shrinks PC ... Active Mode and embedded Fujitsu PalmSecure authentication enable enterprises ... Fujitsu today shows that good things come in small ... to its enterprise desktop and mobile portfolio. Featuring workplace ...
(Date:9/28/2015)... YORK , Sept. 28, 2015  The ... respiration rate and body temperature, is an essential ... can be indicators of deterioration in a patient,s ... hospital, vital signs are typically taken during routine ... hours. If a patient deteriorates between these observation ...
Breaking Biology News(10 mins):